Generic diabetes pill matches brand in healthy volunteer test
NCT ID NCT07479108
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a generic version of empagliflozin (25 mg) works the same as the brand-name drug Jardiance® in 32 healthy adults. Participants took a single dose of each tablet under fasting conditions, and researchers measured drug levels in the blood to check for bioequivalence. The goal was to ensure the generic is a safe and effective alternative.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BIOEQUIVALANCE are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
FS Scientia Pharma
San Luis Potosí City, San Luis Potosí, 78270, Mexico
More trials for these conditions
Other studies related to the condition(s) this trial covers.